281 results on '"Faiena, Izak"'
Search Results
2. MP41-14 HIGH DECIPHER SCORE DEFINES THE SUBGROUP MOST AT RISK OF METASTATIC PROGRESSION AMONG PATIENTS WITH LOWER GRADE TUMORS CLASSIFIED AS NCCN HIGH-RISK BASED ON ELEVATED PROSTATE-SPECIFIC ANTIGEN LEVEL ALONE
3. Treatment utilization and overall survival in patients receiving radical nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma: evaluation of updated treatment guidelines
4. Melanoma-associated antigen-A and programmed death-ligand 1 expression are associated with advanced urothelial carcinoma.
5. Intravesical Therapy for Non-muscle Invasive Bladder Cancer-Current and Future Options in the Age of Bacillus Calmette-Guerin Shortage.
6. Durvalumab: an investigational anti-PD-L1 monoclonal antibody for the treatment of urothelial carcinoma.
7. Adjuvant Therapy for High Risk Localized Kidney Cancer: Emerging Evidence and Future Clinical Trials
8. Gain of Chromosome 5q Predicts a Favorable Prognosis in Localized Renal Cell Carcinoma
9. Survival outcomes in patients with muscle invasive bladder cancer undergoing radical vs. partial cystectomy
10. The association between N-methylnaltrexone, a peripherally acting mu-opioid receptor antagonist, and clinical outcomes in patients undergoing robotic-assisted radical cystectomy
11. Oncologic outcomes in men with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institution international study
12. Diagnostic biomarkers in non-muscle invasive bladder cancer
13. Detection of Individual Prostate Cancer Foci via Multiparametric Magnetic Resonance Imaging
14. Assessment of PSA responses and changes in the rate of tumor growth (g-rate)with immune checkpoint inhibitors in US Veterans with prostate cancer
15. PI-RADSv2 Category on 3 Tesla Multiparametric Prostate MRI Predicts Oncologic Outcomes in Gleason 3+4 Prostate Cancer on Biopsy
16. Overall survival in patients with residual disease after radical cystectomy and neoadjuvant chemotherapy
17. Assessment of PSA responses and changes in the rate of tumor growth (g-rate) with immune checkpoint inhibitors in US Veterans with prostate cancer
18. A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With AdGMCA9 (DC-AdGMCAIX) in Patients With Metastatic Renal Cell Carcinoma
19. Off-Target Effect of Sildenafil on Postsurgical Erectile Dysfunction: Alternate Pathways and Localized Delivery System
20. Accuracy of Multiparametric Magnetic Resonance Imaging for Extracapsular Extension of Prostate Cancer in Community Practice
21. Effect of Uncontrolled Diabetes on Outcomes After Cystectomy in Patients With Bladder Cancer: A Population-Based Study
22. Trends in urinary diversion after radical cystectomy for urothelial carcinoma
23. Editorial Comment
24. Association of Melanoma-Associated Antigen-A and Program-death ligand 1 Expression and Clinical Outcomes in Urothelial Carcinoma
25. Regional Cost Variations of Robot-Assisted Radical Prostatectomy Compared With Open Radical Prostatectomy
26. Controversies in Robotics: Open Versus Robotic Radical Cystectomy
27. Adjuvant Therapy for High Risk Localized Kidney Cancer: Emerging Evidence and Future Clinical Trials
28. Radioisotope-guided Lymphadenectomy for Pelvic Lymph Node Staging in Patients With Intermediate- and High-risk Prostate Cancer (The Prospective SENTINELLE Study).
29. Androgen Receptor
30. List of Contributors
31. ANTI-ANDROGEN THERAPY SUPPRESSES TUMOR GROWTH IN ANDROGEN RECEPTOR-POSITIVE RENAL CELL CARCINOMA: A XENOGRAFT STUDY: MP92-12
32. FROM MOON ROCKS TO KIDNEY STONES: A LOOK AT THE EVOLUTION OF THE CYBERWAND: FRII-11
33. ADRENALECTOMY FOR BENIGN AND MALIGNANT DISEASE: A POPULATION-BASED STUDY ON UTILIZATION AND OUTCOMES FROM 2003-2013: MP12-17
34. OUTCOMES OF MEN WITH LOCALLY ADVANCED (LAPCA) OR REGIONALLY ADVANCED PROSTATE CANCER (RAPCA) FOLLOWING CONSERVATIVE MANAGEMENT (CM): MP09-13
35. Female Urethral Reconstruction
36. Overcoming Immune Resistance in Prostate Cancer: Challenges and Advances
37. PD51-07 SURVIVAL OUTCOMES IN PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER UNDERGOING RADICAL VS PARTIAL CYSTECTOMY: A POPULATION-BASED INVERSE-PROBABILITY WEIGHTED ANALYSIS
38. Bullying has a Potential Role in Pediatric Lower Urinary Tract Symptoms
39. MP72-13 OUTCOMES OF RADICAL CYSTECTOMY IN PATIENTS WITH BLADDER CANCER AND UNCONTROLLED DIABETES: A POPULATION-BASED STUDY
40. PD36-06 EFFICACY OF ROLIPRAM LOADED NANOSPHERES IN LOCALIZED DELIVERY TO SITES OF NERVE INJURY FOR PREVENTION OF POST-PROSTATECTOMY ERECTILE DYSFUNCTION USING A RAT MODEL OF CAVERNOUS NERVE INJURY
41. PD35-09 HIGH-DOSE INTERLEUKEN-2 FOR METASTATIC RENAL CELL CARCINOMA: CONTEMPORARY UTILIZATION TRENDS IN THE UNITED STATES
42. MP53-16 ONCOLOGIC OUTCOMES IN MEN WITH METASTASIS TO THE PROSTATIC ANTERIOR FAT PAD LYMPH NODES: A MULTI-INSTITUTION INTERNATIONAL STUDY
43. MP53-04 SIGNIFICANT INTER-INSTITUTIONAL VARIATIONS IN RACIAL DISPARITIES AMONG AFRICAN-AMERICAN MEN ELIGIBLE FOR PROSTATE CANCER ACTIVE SURVEILLANCE
44. PD60-04 SURVIVAL ANALYSIS AND PREDICTORS OF NON-MUSCLE INVASIVE BLADDER CANCER RECURRENCE IN CLINICAL COMPLETE-RESPONDERS AFTER NEOADJUVANT CHEMOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER
45. MP73-09 EFFECTIVENESS OF COMBINATION CISPLATIN-BASED INTRAVESICAL CHEMOTHERAPY FOR BCG-REFRACTORY BLADDER CANCER
46. Differential expression of melanoma-associated antigen A3/6 and associated immune molecules prior to and post treatment with immune checkpoint inhibitors (ICI) in patients with mUC.
47. Positive surgical margins at radical prostatectomy in the United States: Institutional variations and predictive factors
48. Laparoscopic Bowel Injury in Retroperitoneal Surgery: Current Incidence and Outcomes
49. Durvalumab: an investigational anti-PD-L1 monoclonal antibody for the treatment of urothelial carcinoma
50. Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma and venous thrombus—Trends and effect on overall survival
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.